𝗔𝗰𝗰𝗮𝗻𝗶𝘁𝗼 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀 𝗜𝗻𝗰 𝗖𝗵𝗼𝗼𝘀𝗲𝘀 𝘁𝗵𝗲 𝗕𝗮𝘆 𝗔𝗿𝗲𝗮 𝗮𝘀 𝗜𝘁𝘀 𝗛𝗼𝗺𝗲

We are excited to announce that Accanito Therapeutics Inc has selected the Bay Area as the base for our next phase of growth and innovation.
As an oncology-focused biotech company, we are advancing first-in-class, mitochondria-targeted therapies designed to address multiple tumor types. Establishing our presence in one of the world’s leading life sciences ecosystems positions us to accelerate research, strengthen strategic collaborations, and bring transformative treatments closer to patients.
The Bay Area’s vibrant biotech network, scientific excellence, and innovation-driven culture align perfectly with our mission to redefine cancer therapy at the mitochondrial level.
🔬 Innovation.
🧬 Precision Science.
🌍 Transformative Oncology.